Wells Fargo Initiates Coverage On Pyxis Oncology with Overweight Rating, Announces Price Target of $12

Benzinga Newsdesk www.benzinga.com Neutral 68.4%

Neg 0% Neu 68.4% Pos 0%

Wells Fargo analyst Derek Archila initiates coverage on Pyxis Oncology (NASDAQ:PYXS) with a Overweight rating and announces Price Target of $12.